New Senator Udall Favors Lower Drug Prices, But Not Through Importation
Mark Udall, D-Colo., moves to the Senate with a health care record in the House that includes a "no" vote in 2003 on the Medicare Part D prescription benefit program
You may also be interested in...
Changing the "donut hole" in Medicare Part D drug reimbursement and allowing the government to negotiate prices for seniors' medicines will be on the table as the Obama Administration develops its health care proposals
Sens. Baucus, Grassley Head Down Diverging Paths On Drug Price Negotiation As House Clears Pricing Measure
Baucus now favors repealing the noninterference clause but proceeding “cautiously.” Spotlight shifts to the Senate after the House clears HR 4.
The Congressional Budget Office's determination that prescription drug reimportation would not provide any cost savings could help House/Senate Medicare conferees distance themselves from the House's positive vote on reimportation